Tabah, A.; Lipman, J.; Barbier, F.; Buetti, N.; Timsit, J.-F.; on behalf of the ESCMID Study Group for Infections in Critically Ill Patients—ESGCIP.
Use of Antimicrobials for Bloodstream Infections in the Intensive Care Unit, a Clinically Oriented Review. Antibiotics 2022, 11, 362.
https://doi.org/10.3390/antibiotics11030362
AMA Style
Tabah A, Lipman J, Barbier F, Buetti N, Timsit J-F, on behalf of the ESCMID Study Group for Infections in Critically Ill Patients—ESGCIP.
Use of Antimicrobials for Bloodstream Infections in the Intensive Care Unit, a Clinically Oriented Review. Antibiotics. 2022; 11(3):362.
https://doi.org/10.3390/antibiotics11030362
Chicago/Turabian Style
Tabah, Alexis, Jeffrey Lipman, François Barbier, Niccolò Buetti, Jean-François Timsit, and on behalf of the ESCMID Study Group for Infections in Critically Ill Patients—ESGCIP.
2022. "Use of Antimicrobials for Bloodstream Infections in the Intensive Care Unit, a Clinically Oriented Review" Antibiotics 11, no. 3: 362.
https://doi.org/10.3390/antibiotics11030362
APA Style
Tabah, A., Lipman, J., Barbier, F., Buetti, N., Timsit, J. -F., & on behalf of the ESCMID Study Group for Infections in Critically Ill Patients—ESGCIP.
(2022). Use of Antimicrobials for Bloodstream Infections in the Intensive Care Unit, a Clinically Oriented Review. Antibiotics, 11(3), 362.
https://doi.org/10.3390/antibiotics11030362